Assignee
ATROGI AB
SE11 patents
Top patents by PatentIndex Score
US11357757B2Jun 14, 2022
Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia
ATROGI AB6 citations85
US10288602B2May 14, 2019
Screening method, a kit, a method of treatment and a compound for use in a method of treatement
ATROGI AB7 citations82
US9891212B2Feb 13, 2018
Screening method, a kit, a method of treatment and a compound for use in a method of treatment
ATROGI AB8 citations82
US9784726B2Oct 10, 2017
Screening method, a kit, a method of treatment and a compound for use in a method of treatment
ATROGI AB8 citations82
US9657348B2May 23, 2017
Method of screening compounds for the treatment of diabetes
ATROGI AB9 citations82
US11427539B2Aug 30, 2022
Beta-hydroxy heterocyclic amines and their use in the treatment of hyperglycaemia
ATROGI AB3 citations71
US12280023B2Apr 22, 2025
Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
ATROGI AB0 citations61
US12036210B2Jul 16, 2024
Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia
ATROGI AB0 citations61
US11648216B2May 16, 2023
Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
ATROGI AB1 citations61
US12378216B2Aug 5, 2025
Heteroaryl(heterocyclyl)methanol compounds useful in the treatment of hyperglycaemia
ATROGI AB0 citations50
US11793774B2Oct 24, 2023
Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia
ATROGI AB0 citations50